Development and validation of Alzheimer’s Disease Animal Model for the Purpose of Regenerative Medicine
- 13 May 2019
- journal article
- review article
- Published by Springer Nature in Cell and Tissue Banking
- Vol. 20 (2) , 141-151
Abstract
One of the most common age-related neurodegenerative disorders is Alzheimer’s disease which globally threatening the health of elderly people. Although there are several pharmacological and non- pharmacological treatments for Alzheimer’s disease, they can just decrease the symptoms in these diseases. In this context, cell therapy and regenerative medicine approach as the novel therapeutic strategies for neurodegenerative diseases would be important. Based on scientific research principles, using any novel therapeutic approaches before the run in clinical trials need to take preclinical (animal study) stapes. Accordingly, an animal study can improve our understanding of biological mechanisms of diseases and as an important step should adhering to ethical guidelines and standards. On the other hand, to gain suitable outcomes, it is important to check the appropriate validation of animal models. In this regard, the present review would discuss about the development and validation of appropriate AD animal models in the field of regenerative medicine.Keywords
This publication has 63 references indexed in Scilit:
- Current and future treatments for Alzheimer’s diseaseTherapeutic Advances in Neurological Disorders, 2012
- Brain imaging in the study of Alzheimer's diseaseNeuroImage, 2012
- The Clinical Problem of Symptomatic Alzheimer Disease and Mild Cognitive ImpairmentCold Spring Harbor Perspectives in Medicine, 2012
- Brain Imaging in Alzheimer DiseaseCold Spring Harbor Perspectives in Medicine, 2012
- Animal models in the drug discovery pipeline for Alzheimer's diseaseBritish Journal of Pharmacology, 2011
- Alzheimer's Disease: Diagnosis and Treatment Across the Spectrum of Disease SeverityMount Sinai Journal of Medicine: A Journal of Translational and Personalized Medicine, 2011
- Stem cell technology for neurodegenerative diseasesAnnals of Neurology, 2011
- Genetic Aspects of Alzheimer DiseaseThe Neurologist, 2009
- Evaluation of animal models of neurobehavioral disordersBehavioral and Brain Functions, 2009
- The Role of Animal Models in Evaluating Reasonable Safety and Efficacy for Human Trials of Cell-Based Interventions for Neurologic ConditionsJournal of Cerebral Blood Flow & Metabolism, 2008